Print Page     Close Window     

SEC Filings

BIOTIME INC filed this Form 10-Q on 08/09/2017
Entire Document

IN WITNESS WHEREOF, the parties have executed this Warrant as of the date above written.
Cell Cure Neurosciences Ltd.
By: Dr. Charles Irving
Title: CEO

Agreed and accepted:
HBL-Hadasit Bio-Holdings Ltd.
[ * ] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

© Copyright BioTime, Inc.